Results 61 to 70 of about 1,726,301 (219)

Liver transplantation for alcoholic liver disease [PDF]

Clinical Liver Disease, 2013
Alcoholism is a disease of remission and relapse. A lapse in abstinence tends to be viewed as a failure to commit to abstinence, and an acknowledged relapse may lead to the patient's removal from the liver transplant list; however, such a relapse may actually offer insight into alcoholism.
Patrizia, Burra, Michael R, Lucey
openaire   +2 more sources

A dual-lobe strategy in living-donor liver transplantation: overcoming small-for-size graft limitations in an obese patient: a case report

Clinical Transplantation and Research
The primary goal of living donor liver transplantation (LDLT) is to optimize outcomes for the recipient while ensuring donor safety. However, there is a risk of small-for-size syndrome, particularly in obese patients, where graft weight might be ...
Bhabani Sankar Sahoo, Kausar Makki, Yogesh Yadav, Tathagata Karan, Piyush Srivastava, Vivek Vij   +5 more
doaj   +1 more source

Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center

BMC Gastroenterology, 2023
Background Regorafenib is an oral multikinase inhibitor and became the first second-line systemic treatment for hepatocellular carcinoma (HCC) following the phase III RESORCE trial.
Qingwei Zhu, Wei Rao, Junyu Huo, Zixiang Li, Song Wang, Wensheng Qiu, Ge Guan, Yang Xin, Ning Fan, Jinzhen Cai, Liqun Wu   +10 more
doaj   +1 more source

Natural Killer Cells in Liver Disease [PDF]

, 2017
Natural killer (NK) cells comprise one of the most abundant immune cell populations in human liver and the nature and functions of these cells have been a focus of recent interest.
Stegmann, KA, Male, V, Nicholas Easom, Maini, MK, Maini, Mala K, Stegmann, Kerstin A, Kerstin Stegmann, Victoria Male, Easom, NJ, Easom, Nicholas J, Male, Victoria, Mala Maini   +11 more
core   +1 more source

Alcoholic Liver Disease

Medical Clinics of North America, 1989
Alcohol has been implicated in the genesis of liver disease for centuries. Significant progress has been made in our understanding of the pathogenesis of ALD. It is now apparent that both the consumption and the metabolism of alcohol promote the production of inflammatory mediators (cytokines) that result in hepatotoxicity and fibrogenesis.
openaire   +3 more sources

Autoimmune hepatitis and overlap syndrome among Alaska Native people: Prevalence, clinical characteristics, and remission

JGH Open, 2023
Background and Aim High autoimmune hepatitis (AIH) and overlap syndrome (OS) prevalence have been previously documented among Alaska Native people. The purpose of this project is to report changes in AIH/OS prevalence over time, clinical characteristics,
Janet M. Johnston, Brian McMahon, Lisa Townshend‐Bulson, Julia Plotnik, Paarth Jain, Meggan Judge, Wileina Rhodes, Chriss Homan   +7 more
doaj   +1 more source

ADULT LIVER TRANSPLANTATION FOR METABOLIC LIVER DISEASE

, 1998
Inborn errors of metabolism are a recognizable cause of acute or chronic liver disease, as either fulminant hepatic failure, cirrhosis, or hepatocellular carcinoma. Improved survival rates following whole-organ orthotopic liver transplantation (OLT) have
Martin, Paul, Stribling, Rise, Goss, John A   +2 more
core   +1 more source

Urinary Recovery of Salicylamide as Its Glucuronide in Liver Disease

, 1962
An attempt was made to establish the method for the estimation of glucuronide formation in vivo using salicylamide and further to study the alteration in the glucuronide formation in liver disease. The results were as follows: 1.
Taketa, Kazuhisa
core   +1 more source

Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China

European Journal of Medical Research
Aim Cardiovascular disease morbidity and mortality rates are high in patients with metabolic dysfunction-associated fatty liver disease (MAFLD). The objective of this study was to analyze the risk factors and differences between lean MAFLD and overweight
Ruya Zhu, Caicai Xu, Suwen Jiang, Jianping Xia, Boming Wu, Sijia Zhang, Jing Zhou, Hongliang Liu, Hongshan Li, Jianjun Lou   +9 more
doaj   +1 more source

Liver Disease [PDF]

Clinical Science, 1994
T, Tsuji, T, Higashi, H, Shimomura
openaire   +4 more sources